Results 221 to 230 of about 488,286 (382)

Teaching neurons to respond to placebos

Journal of Physiology, 2016
F. Benedetti, E. Frisaldi, E. Carlino, Lucia Giudetti, Alan Pampallona, M. Zibetti, M. Lanotte, L. Lopiano   +7 more
semanticscholar   +1 more source

SHORT-TERM CLINICAL TRIAL of PROPRANOLOL IN RACEMIC FORM (INDERAL), D-PROPRANOLOL and PLACEBO IN MIGRAINE

, 1976
Per Stensrud, Ottar Sjaastad
openalex   +1 more source

On blaming the placebo [PDF]

Arthritis & Rheumatism, 1991
Curtis J. Henke, Wallace V. Epstein
openaire   +3 more sources

Medication adherence during the run‐in phase of clinical trials: A systematic review of methodological and reporting rigour

British Journal of Clinical Pharmacology, EarlyView.
Aims Trial run‐in phases are sometimes used to select adherent participants as a strategy to enrich trials, but the methods employed lack clear regulatory guidance and there are concerns about the transparency of reporting. This review aims to characterize the methods used for adherence measurement and public reporting of run‐in studies.
Non Davies, Bernard Vrijens, Daniel F. B. Wright, Dyfrig A. Hughes   +3 more
wiley   +1 more source

Putting placebos to the test. [PDF]

PLoS Biology, 2017
Liza Gross
doaj   +1 more source

Addressing blinding in classic psychedelic studies with innovative active placebos. [PDF]

Int J Neuropsychopharmacol
Aday JS, Simonsson O, Schindler EAD, D'Souza DC.   +3 more
europepmc   +1 more source

Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial.

, 1979
Karna Dev Bardhan, Dominik Saul, Rotherham Hospital, John Edwards, Paul Smith, Llandough Hospital, M. R. Fettes, J. A. H. Forrest, R C Heading, Robert A. Logan, M W Dronfield, M J Langman, W Larkworthy, Nocton Hall, S J Haggie, J H Wyllie, Chris Corbett, H L Duthie, I Fussey, C.H. Holdsworth, G. V. Balmforth, Takashi Maruyama   +21 more
openalex   +1 more source

The Effect of Dydrogesterone on Premenstrual Symptoms:A Double-blind, Randomized, Placebo-controlled Study in General Practice [PDF]

, 1988
Vibeke Hoffmann, Poul A. Pedersen, John Philip, Pia Fly, Christian Brahe Pedersen   +4 more
openalex   +1 more source

Problematic placebos in physical therapy trials.

Journal of Evaluation In Clinical Practice, 2016
M. Maddocks, R. Kerry, Andrew Turner, J. Howick   +3 more
semanticscholar   +1 more source

Mild psoriasis as a suitable model for proof‐of‐mechanism in a phase 1B setting: Results from a double‐blind placebo‐controlled trial with guselkumab

British Journal of Clinical Pharmacology, EarlyView.
Aims Early clinical development of novel psoriasis therapies is hampered by a decreasing number of moderate‐to‐severe psoriasis patients eligible for participation in trials since efficacious treatments, such as biologics, have become widely available.
Jannik Rousel, Menthe E. Bergmans, Lisa J. Bruijnincx, Sissi Lin, Tessa Niemeyer‐van der Kolk, Roman Bohoslavsky, Yalçin Yavuz, Naomi B. Klarenbeek, Joke A. Bouwstra, Robert Rissmann, Martijn B. A. van Doorn, the Next‐Generation ImmunoDermatology Consortium (NGID)   +11 more
wiley   +1 more source